The earnings call highlighted significant revenue growth, successful product launches, and strategic expansions. Despite some challenges with gross margin and operating expenses, the company's strong cash position and strategic partnerships position it well for future growth.

Company Guidance

During the second quarter of 2025, ClearPoint Neuro, Inc. provided guidance emphasizing their strategic initiatives and financial performance. The company reported total revenue of $9.2 million, marking a 17% increase compared to the same period in 2024. This growth was driven by a 33% boost in neurosurgery navigation revenue and a 10% rise in biologics and drug delivery revenue. ClearPoint's operating expenses increased by 16% to $11.2 million, reflecting investments in research and development, sales and marketing, and general administrative costs. The company ended the quarter with cash and cash equivalents of $41.5 million. They highlighted strategic advancements, including the expansion of their global installed base to over 100 centers and regulatory clearance in 36 countries. ClearPoint also focused on product innovations such as the ClearPoint ICT navigation software and PRISM Laser Therapy system. The guidance underscored their commitment to supporting over 60 biopharma partners, with several programs in the FDA expedited review process, and reiterated their goal of making significant strides in the cell and gene therapy market.

Record Revenue Growth

Total revenue for Q2 2025 was $9.2 million, a 17% increase from $7.9 million in Q2 2024, driven by growth across all segments.

Biologics and Drug Delivery Expansion

Biologics and drug delivery revenue increased by 10% to $4.7 million, with a 12% increase in product revenue and an 8% increase in service revenue.

Neurosurgery Navigation Revenue Surge

Neurosurgery navigation revenue increased by 33% to $3.4 million, attributed to new product offerings and additional placements.

Strong Cash Position

Cash and cash equivalents rose to $41.5 million as of June 30, 2025, from $20.1 million at the end of 2024.

Global Expansion and Regulatory Clearances

ClearPoint technology is now available at more than 100 centers globally and has regulatory clearance in 36 countries, with expansions into Canada, Japan, and China initiated.

3.0 Navigation Software Success

The new 3.0 ClearPoint ICT navigation software has been well-received, with deployment in 35 sites and showing improved procedure efficiency and accuracy.

Partnership with Oberland Capital

Secured funding from Oberland Capital in both debt and equity forms, supporting long-term strategic initiatives.

ClearPoint Neuro (CLPT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CLPT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	-0.20 / -	-0.18	―	―	―
Aug 12, 2025	2025 (Q2)	-0.20 / -0.21	-0.16	-31.25% (-0.05)	―
May 13, 2025	2025 (Q1)	-0.16 / -0.22	-0.16	-37.50% (-0.06)	―
Feb 26, 2025	2024 (Q4)	-0.16 / -0.20	-0.18	-11.11% (-0.02)
Nov 07, 2024	2024 (Q3)	-0.17 / -0.18	-0.2	10.00% (+0.02)
Aug 07, 2024	2024 (Q2)	-0.20 / -0.16	-0.29	44.83% (+0.13)
May 07, 2024	2024 (Q1)	-0.19 / -0.16	-0.23	30.43% (+0.07)	―
Mar 12, 2024	2023 (Q4)	-0.20 / -0.18	-0.18	0.00% (0.00)	―
Nov 09, 2023	2023 (Q3)	-0.25 / -0.20	-0.15	-33.33% (-0.05)
Aug 08, 2023	2023 (Q2)	-0.19 / -0.29	-0.18	-61.11% (-0.11)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CLPT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 12, 2025	$10.54	$11.92	+13.09%
May 13, 2025	$14.20	$12.43	-12.46%
Feb 26, 2025	$17.22	$14.20	-17.54%
Nov 07, 2024	$13.42	$11.65	-13.19%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does ClearPoint Neuro (CLPT) report earnings?

ClearPoint Neuro (CLPT) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).

What is ClearPoint Neuro (CLPT) earnings time?

ClearPoint Neuro (CLPT) earnings time is at Nov 11, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CLPT EPS forecast?

CLPT EPS forecast for the fiscal quarter 2025 (Q3) is -0.2.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing